CLINICAL_TRIALS
trial_result
· 2020-10-08
Clinical Trial Update: Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder [Phase 2]
Summary
Phase 2 clinical trial assessing GET73 on brain glutamate and GABA in individuals with alcohol use disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Laboratorio Farmaceutico Ct S.r.l. | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED